STEQEYMA IV
Google image searchProduct monograph
Active ingredient
ustekinumab, 5 MG/ML
DIN: 02550261
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE VIAL
Schedule: Prescription / Schedule D
Company: CELLTRION INC.
Date: 29-AUG-2024
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AC — Interleukin inhibitors (ATC, ATC/DDD)
- L04AC05 — USTEKINUMAB (ATC/DDD)
Reference brand drug: Stelara
